U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(8)
(3)
(17)
(11)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(33)
(23)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(123)
(20)
(1)
(1)
(640)
0 of 5
(7)
(1)
(3)
(8)
(7)
(31)
(1)
(10)
(7)
(3)
(13)
(1)
(1)
(1)
(1)
(105)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(6)
(49)
(2)
(121)
(14)
(55)
(2)
(30)
(6)
(4)
(1)
(7)
(1)
(2)
(405)
(2)
(6)
(13)
(2)
(1)
0 of 43
(7)
(2)
(40)
(1)
(3)
(2)
(2)
(7)
0 of 8
(53)
(6)
(5)
(1)
(3)
(12)
(564)
(1)
(1)
(28)
(41)
(63)
0 of 12
(455)
(31)
(270)
(1)
0 of 4
(130)
(19)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(16)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(1)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(30)
(1)
(8)
(21)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(7)
(6)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(1)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(2)
(4)
(5)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(4)
(6)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(92)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(1)
(1)
(2)
(3)
(11)
(2)
(3)
(3)
(3)
(2)
(2)
(6)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(7)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(12)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(8)
(3)
(2)
(3)
(2)
(5)
(3)
(2)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(21)
(4)
(2)
(6)
(30)
(19)
(19)
(2)
(4)
(2)
(8)
(2)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(2)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(7)
(6)
(6)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(15)
(2)
(3)
(5)
(32)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(2)
(2)
(2)
(5)
(3)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(3)
(4)
(3)
(4)
(64)
(2)
(3)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(6)
(3)
(13)
(8)
(3)
(78)
(3)
(12)
(7)
(3)
(5)
(3)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(5)
(5)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(10)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(5)
(4)
(2)
(4)
(2)
(2)
(2)
(12)
(10)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(4)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(2)
(32)
(5)
(4)
(6)
(5)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(2)
(3)
(2)
(14)
(3)
(3)
(3)
(2)
(3)
(4)
(5)
(2)
(3)
(2)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(4)
(29)
(2)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(167)
(2)
(4)
(3)
(2)
(2)
(2)
(5)
(6)
(7)
(4)
(4)
(10)
(4)
(11)
(5)
(5)
(4)
(2)
(2)
(36)
(5)
(4)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(4)
(2)
(2)
(2)
(2)
(6)
(2)
(2)
(17)
(2)
(2)
(2)
(6)
(2)
(13)
(2)
(16)
(5)
(5)
(4)
(4)
(3)
(24)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(31)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(166)
(24)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(7)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(5)
(5)
(2)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(3)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(37)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(6)
(4)
(5)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(3)
(9)
(2)
(12)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(5)
(3)
0 of 1000
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(10)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(6)
(2)
(2)
(3)
(3)
(4)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(270)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(2)
(3)
(2)
(5)
(2)
(3)
(1)
(19)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(4)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(17)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(142)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
0 of 436
(1)
(1)
(8)
(4)
(1)
(1)
(8)
(88)
(3)
(48)
(231)
(1)
(25)
(1)
(78)
(1)
(27)
(2)
(7)
(145)
(1)
(4)
(1)
(4)
0 of 24
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 227
Showing 21 - 40 of 786 results
  • Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2020
    Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020
    United States. Advisory Committee on Immunization Practices.  ...
    1/29/2020
    Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American Academy of Pediatrics (www.aap.org), American Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and American ...
    Current Public Domain
  • Recommended adult immunization schedule for ages 19 years or older United States 2020
    Recommended adult immunization schedule for ages 19 years or older, United States, 2020
    United States. Advisory Committee on Immunization Practices.  ...
    1/29/2020
    Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for DiseaseControl and Prevention (www.cdc.gov), American College of Physicians (www.acponline.org), American Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and Ame ...
    Current Public Domain
  • Treatment of drugresistant tuberculosis An official ATSCDCERSIDSA clinical practice guideline
    Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
    Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.
    11/15/2019 | American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 10,
    The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well ...
    Current Public Domain
  • Recommended adult immunization schedule for ages 19 years or older United States 2019
    Recommended adult immunization schedule for ages 19 years or older, United States, 2019
    United States. Advisory Committee on Immunization Practices.  ...
    02/01/2019
    cdc:51362Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American College of Physicians (www.acponline.org), Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and Am ...
    Superseded Supporting Files Public Domain
  • Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2019
    Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019
    United States. Advisory Committee on Immunization Practices.  ...
    01/31/2019
    cdc:51363Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American Academy of Pediatrics (www.aap.org), American Academy of Family Physicians (www.aafp.org), and American College of Obstetricians and Gynecologists (www.acog.org). ...
    Superseded Supporting Files Public Domain
  • Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
    Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
    Nelson NP, Link-Gelles R, Hofmeister MG, et al.
    November 2, 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    ACIP recommendation for hepatitis A vaccination for post-exposure prophylaxis and International Travel
    Current Public Domain
  • Appendices 1 Grading Scheme and 2 Criteria for Inclusion of Citations for Information for Providers to Share with Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection Sexually Transmitted Infections and other Health Outcomes
    Appendices: 1) Grading Scheme, and 2) Criteria for Inclusion of Citations, for "Information for Providers to Share with Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outcomes"
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.
    8/28/2018
    Appendix 1. Grading Scheme and Criteria for Inclusion of Citations. Appendix 1 includes the grading scheme and criteria for inclusion of citations and specific considerations for use of the scheme for Information for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV infection, Sexually Transmitted ...
    Public Domain
  • Background Methods and Synthesis of Scientific Information Used to Inform Information for Providers to Share with Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection Sexually Transmitted Infections and other Health Outcomes
    Background, Methods, and Synthesis of Scientific Information Used to Inform “Information for Providers to Share with Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outcomes”
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.
    8/22/2018
    This is a companion document to Information for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV infection, Sexually Transmitted Infections, and other Health Outcomes that describes the methods for evidence review and provides a description of the evidence about the preventive health benefits, saf ...
    Public Domain
  • Information for providers counseling male patients and parents regarding male circumcision and the prevention of HIV infection STIs and other health outcomes
    Information for providers counseling male patients and parents regarding male circumcision and the prevention of HIV infection, STIs, and other health outcomes
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.
    8/22/2018
    This document is intended to assist health care providers in the United States who share information with men and parents of male infants during decision making about male circumcision conducted by health care providers (i.e., medically performed) as it relates to the prevention of human immunodeficiency virus (HIV) infection, sexually transmitted ...
    Current Public Domain
  • Peer Review Comments and CDC Responses for Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection STIs and other Health Outcomes and Background Methods and Synthesis of Scientific Information Used to Inform the Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV infection STIs and other Health Outcomes
    Peer Review Comments and CDC Responses for “Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, STIs, and other Health Outcomes” and “Background, Methods, and Synthesis of Scientific Information Used to Inform the ‘Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV infection, STIs, and other Health Outcomes.’”
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.
    7/27/2018
    This document presents a compilation of all the comments received and the corresponding CDC responses during the second peer review comment period for the document: Information for Providers to Share with Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outc ...
    Public Domain
  • 2018 annex to the Model Aquatic Health Code Scientific rationale 3rd Edition July 2018
    2018 annex to the Model Aquatic Health Code: Scientific rationale, 3rd Edition, July 2018
    Centers for Disease Control and Prevention (U.S.)  ...
    July 2018
    3rd edition, July 2018This information is distributed solely as guidance for the purpose of assisting state and local health departments, aquatic facility inspection programs, building officials, the aquatics industry, and other interested parties in improving the health and safety at public aquatic facilities. This document does not address all he ...
    Public Domain
  • 2018 Model Aquatic Health Code Code language 3rd Edition July 2018
    2018 Model Aquatic Health Code: Code language, 3rd Edition, July 2018
    Centers for Disease Control and Prevention (U.S.)  ...
    July 2018
    3rd edition, July 2018This information is distributed solely as guidance for the purpose of assisting state and local health departments, aquatic facility inspection programs, building officials, the aquatics sector, and other interested parties in improving the health and safety at public aquatic facilities. This document does not address all heal ...
    Public Domain
  • Update of Recommendations for Use of OnceWeekly IsoniazidRifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
    Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
    Borisov, Andrey S. ;
    Bamrah Morris, Sapna
    June 29. 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Treatment of latent tuberculosis infection (LTBI) is critical to the control and elimination of tuberculosis disease (TB) in the United States. In 2011, CDC recommended a short-course combination regimen of once-weekly isoniazid and rifapentine for 12 weeks (3HP) by directly observed therapy (DOT) for treatment of LTBI, with limitations for use in ...
    Current Supporting Files Public Domain
  • Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir Implications for HIV Postexposure Prophylaxis PEP
    Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP)
    Centers for Disease Control and Prevention (U.S.).
    05/23/2018
    Guidance to providers regarding the use of Dolutegravir. A preliminary unscheduled analysis of data from an ongoing NIH-funded observational study in Botswana suggests that an increased risk of neural tube defects was associated with exposure to antiretroviral (ARV) regimens that include dolutegravir (DTG) at conception.
    Current Public Domain
  • Morbidity and Mortality Weekly Report MMWR Recommendations and Reports Vol 67 No 2 April 27 2018
    Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports / Vol. 67 / No. 2, April 27, 2018
    Liang, Jennifer L. ;
    Tiwari, Tejpratap
    April 27, 2018 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report compiles and summarizes all recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previously published recommendations, this report does not contain any new recommendations and replaces all ...
    Current Public Domain
  • Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2017 Update Clinical Practice Guideline
    Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline
    United States. Public Health Service.  ...
    March 2018
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis forthe Prevention of HIV Infection in the United States – 2016: Update – A Clinical Practi ...
    Public Domain
  • Preexposure prophylaxis for the prevention of HIV infection in the United States 2017 Update clinical providers supplement
    Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 Update clinical providers’ supplement
    United States. Public Health Service.  ...
    March 2018
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Providers’ Supplement was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States -2 ...
    Superseded Public Domain
  • Recommended immunization schedule for children and adolescents aged 18 years or younger United States 2018
    Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2018
    United States. Advisory Committee on Immunization Practices.  ...
    2/5/2018
    • Consult relevant ACIP statements for detailed recommendations (www.cdc.gov/vaccines/hcp/acip-recs/index.html).• When a vaccine is not administered at the recommended age, administer at a subsequent visit.• Use combination vaccines instead of separate injections when appropriate.• Report clinically significant adverse events to the Vaccine Adverse ...
    Public Domain
  • Recommended immunization schedule for adults aged 19 years or older United States 2018
    Recommended immunization schedule for adults aged 19 years or older, United States, 2018
    United States. Advisory Committee on Immunization Practices.  ...
    1/24/2018
    In February 2018, the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018 became effective, as recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the Centers for Disease Control and Prevention (CDC). The adult immunization schedule was also approved by the American College of ...
    Public Domain
  • Vessel Sanitation Program 2018 construction guidelines
    Vessel Sanitation Program 2018 construction guidelines
    Vessel Sanitation Program (U.S.)  ...
    2018
    The VSP 2018 Construction Guidelines went into effect on June 1, 2018.Information that has changed from the 2011 version of the VSP Operations Manual is marked with a |The Centers for Disease Control and Prevention (CDC) established the Vessel Sanitation Program (VSP) in 1975 as a cooperative endeavor with the cruise vessel industry. VSP’s goal is ...
    Public Domain
21 - 40 / 786